Michael Crawford, MD
Clinical Cardiac Electrophysiology · Salt Lake City, UTNPI 1629422159
Payments from drug & device makers
What this record shows
This record is dominated by grants: $27,550 of the $29,958 with a category attached, or 92.0%. 8 manufacturers reported payments, led by Abbott at 48.0% of the total. Reporting peaked in 2023 at $10,567 and has fallen 98.9% since, to $113 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in UT, where the typical reported total is $33,716.
Across 45 payments — averaging $665.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$14K
- Boston Scientific$13K
- Medtronic$2K
- Biosense Webster, Inc.$371
- AstraZeneca$330
- Biotronik Inc.$134
- plus $100 from 2 others
What the payments were for
- Grants$27,55092%
- Travel & lodging$3681%
- Food & beverage$1,2784%
- Education$7633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $14,385 |
| Boston Scientific | 5 | $12,703 |
| Medtronic | 8 | $1,937 |
| Biosense Webster, Inc. | 8 | $371 |
| AstraZeneca | 5 | $330 |
| Biotronik Inc. | 1 | $134 |
| Astellas Pharma US Inc | 2 | $81 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$5,000
- HeartMate 3 Left Ventricular Assist Device$322
- ENSITE$146
- Acticor 7 VR-T DX$134
- Micra$105
- QDOT MICRO Catheter$104
- FARXIGA$102
How this compares
$29,958 in reported general payments places this provider in the 45th percentile of 29 clinical cardiac electrophysiology providers in Utah.
See all clinical cardiac electrophysiology providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $55,061 |
| Flecainide Acetate | 46 | $1,998 |
| Metoprolol Succinate | 31 | $523 |
| Sucralfate | 31 | $465 |
| Omeprazole | 35 | $409 |
| Amiodarone Hcl | 23 | $323 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Salt Lake City
- Ravi RanjanSalt Lake City$345K
- John DaySalt Lake City$313K
- Roger FreedmanSalt Lake City$177K
- Nischala NannapaneniSalt Lake City$57K
- Helge LehmannSalt Lake City$49K
- Richard SheltonSalt Lake City$47K
- Anish ShahSalt Lake City$43K
- Qussay MarashlySalt Lake City$34K
- Jared MillerSalt Lake City$8K
- Travis WallSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.